SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737287-23-000053
Filing Date
2023-05-03
Accepted
2023-05-03 16:09:08
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q allo-20230331.htm   iXBRL 10-Q 1450772
2 EX-10.1 allo-20230331xex101.htm EX-10.1 61382
3 EX-10.2 allo-20230331xex102.htm EX-10.2 63267
4 EX-10.3 allo-20230331xex103.htm EX-10.3 153612
5 EX-31.1 allo-20230331xex311.htm EX-31.1 9885
6 EX-31.2 allo-20230331xex312.htm EX-31.2 9855
7 EX-32.1 allo-20230331xex321.htm EX-32.1 7110
13 allogenefootera.jpg GRAPHIC 3922
14 allogenelogoa.jpg GRAPHIC 14655
  Complete submission text file 0001737287-23-000053.txt   6824670

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allo-20230331.xsd EX-101.SCH 46408
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allo-20230331_cal.xml EX-101.CAL 51026
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allo-20230331_def.xml EX-101.DEF 242059
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allo-20230331_lab.xml EX-101.LAB 600472
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allo-20230331_pre.xml EX-101.PRE 370554
60 EXTRACTED XBRL INSTANCE DOCUMENT allo-20230331_htm.xml XML 936830
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38693 | Film No.: 23883766
SIC: 2836 Biological Products, (No Diagnostic Substances)